Clinically Significant Prostate Cancer Diagnosis Without Histological Proof: A Possibility in the Prostate-specific Membrane Antigen Era?
Author:
Publisher
Elsevier BV
Subject
Urology
Reference10 articles.
1. EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer—2020 update. Part 1: screening, diagnosis, and local treatment with curative intent;Mottet;Eur Urol,2021
2. MRI-targeted or standard biopsy for prostate-cancer diagnosis;Kasivisvanathan;N Engl J Med,2018
3. The additive diagnostic value of prostate-specific membrane antigen positron emission tomography computed tomography to multiparametric magnetic resonance imaging triage in the diagnosis of prostate cancer (PRIMARY): a prospective multicentre study;Emmett;Eur Urol,2021
4. Emmett LM, Papa N, Buteau J, et al. The PRIMARY score: using intra-prostatic PSMA PET/CT patterns to optimise prostate cancer diagnosis. J Nucl Med. In press. https://doi.org/10.2967/jnumed.121.263448.
5. Ptasznik G, Papa N, Kelly BD, et al. High PSMA PET SUVmax in PI-RADS 4 or men confers a high probability of significant prostate cancer. BJU Int. In press. https://doi.org/10.1111/bju.15736.
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The role of nuclear medicine tracers for prostate cancer surgery: from preoperative to intraoperative setting;Current Opinion in Urology;2023-08-02
2. Immunohistochemical and histopathological validation of 18F‐PSMA‐1007 PET/CT for intraprostatic cancerous lesions;The Prostate;2023-07-16
3. Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Active Surveillance for Prostate Cancer Trial (PASPoRT);European Urology Oncology;2023-06
4. Prostate Cancer Diagnosis Without Histological Proof: Is Treating Images Reasonable?;European Urology Open Science;2022-12
5. Re: Joris G. Heetman, Lieke Wever, Leonor J. Paulino Pereira, Roderick C.N. van den Bergh. Clinically Significant Prostate Cancer Diagnosis Without Histological Proof: A Possibility in the Prostate-specific Membrane Antigen Era? Eur Urol Open Sci 2022;44:30–2;European Urology Open Science;2022-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3